Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synaffix BV

Division of SynAffix BV
www.synaffix.com

Latest From Synaffix BV

Asia Deal Watch: Antibody-Drug Conjugates Reign With Alliances Involving Celltrion, Miracogen & WuXi Biologics

Celltrion and iProgen will co-develop ADC candidates, Miracogen and Synaffix sign a technology license after a successful research collaboration, and WuXi will provide clinical trial material to NBE Therapeutics.

Deals Commercial

Deal Making: If I Knew Then What I Know Today

David Chiswell, Jane Dancer and Konstantinos Efthymiopoulos shared lessons they have learnt over the years about deal making at this year's 'If I Knew Then What I Know Today' panel at the AngloNordic meeting in London.

Deals StartUps and SMEs
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • SynAffix BV
  • Senior Management
  • Peter van de Sande, CEO
    Floris van Delft, PhD, CSO
    Anthony DeBoer, Dir., Bus. Dev.
  • Contact Info
  • Synaffix BV
    Phone: 88 022 4505
    Pivot Pk., RE Bldg.
    Indust. 66
    Oss, 5349 AE
    Netherlands
Advertisement
Advertisement
UsernamePublicRestriction

Register